These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14722944)

  • 21. Depression induced by orlistat (Xenical).
    Benazzi F
    Can J Psychiatry; 2000 Feb; 45(1):87. PubMed ID: 10696499
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison table: some FDA-approved drugs for weight management.
    Med Lett Drugs Ther; 2018 Jun; 60(1548):e98-e100. PubMed ID: 29913464
    [No Abstract]   [Full Text] [Related]  

  • 23. I am about 15 lbs. overweight. Do you recommend the new over-the-counter diet pill Alli?
    Johns Hopkins Med Lett Health After 50; 2007 Jun; 19(4):8. PubMed ID: 17647299
    [No Abstract]   [Full Text] [Related]  

  • 24. The obesity pandemic--how did we get here?
    Malone M
    Ann Pharmacother; 2007 Sep; 41(9):1497-8. PubMed ID: 17652122
    [No Abstract]   [Full Text] [Related]  

  • 25. The fat of the matter.
    Nat Med; 2012 Aug; 18(8):1155. PubMed ID: 22869166
    [No Abstract]   [Full Text] [Related]  

  • 26. Lorcaserin for weight loss: insights into US Food and Drug Administration approval.
    Miller LE
    J Acad Nutr Diet; 2013 Jan; 113(1):25-30. PubMed ID: 23260720
    [No Abstract]   [Full Text] [Related]  

  • 27. The advances on the knowledge base of obesity and future therapeutic directions.
    Vettor R; Pagano C; Federspil G
    Eat Weight Disord; 2001 Sep; 6(3 Suppl):40-3. PubMed ID: 11706508
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The FDA's risk/benefit calculus in the approvals of Qsymia and Belviq: treating an obesity epidemic while avoiding another fen-phen.
    Azebu LM
    Food Drug Law J; 2014; 69(1):87-111, ii-iii. PubMed ID: 24772687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orlistat: current status in clinical therapeutics.
    McClendon KS; Riche DM; Uwaifo GI
    Expert Opin Drug Saf; 2009 Nov; 8(6):727-44. PubMed ID: 19998527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development.
    Bays HE
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):265-77. PubMed ID: 21438803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does orlistat really offer help for the treatment of obesity?].
    Orozco P
    Aten Primaria; 1999 Nov; 24(8):445-6. PubMed ID: 10630025
    [No Abstract]   [Full Text] [Related]  

  • 33. Obesity: can a new drug help?
    Harv Mens Health Watch; 1999 Oct; 4(3):6-8. PubMed ID: 10529295
    [No Abstract]   [Full Text] [Related]  

  • 34. Another weight-loss drug approved.
    Harv Womens Health Watch; 1999 Jul; 6(11):7. PubMed ID: 10368549
    [No Abstract]   [Full Text] [Related]  

  • 35. Outdated and misleading review of orlistat.
    Van R; Walt L
    Can Fam Physician; 1999 Dec; 45():2849-50, 2852. PubMed ID: 10626048
    [No Abstract]   [Full Text] [Related]  

  • 36. Contrave--a combination of bupropion and naltrexone for weight loss.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):112-4. PubMed ID: 25372849
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacotherapy and surgery treatment for the severely obese adolescent.
    Woo T
    J Pediatr Health Care; 2009; 23(4):206-12; quiz 213-5. PubMed ID: 19559988
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comment of J. Fritze: Is therapy of obesity with orlistat medically necessary?].
    Wirth A
    Versicherungsmedizin; 1999 Sep; 51(3):137-8; author reply 138-9. PubMed ID: 10516837
    [No Abstract]   [Full Text] [Related]  

  • 39. Diet-drug dilemma.
    Blackburn G
    Health News; 1999 Jun; 5(7):2. PubMed ID: 10932774
    [No Abstract]   [Full Text] [Related]  

  • 40. Exploring the effects of orlistat and guidance on its use to achieve weight loss in patients.
    Abbott D
    Nurs Times; 2009 May 26-Jun 1; 105(20):24. PubMed ID: 19534189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.